Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia

Human Gene Therapy

Volumn 10, Issue 6, 1999, Pages 899-909

  Standiford, Theodore J ^a,b   Wilkowski, Jodi M ^a   Sisson, Thomas H ^a   Hattori, Noboru ^a   Mehrad, Borna ^a   Bucknell, Kathy A ^a   Moore, Thomas A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; TUMOR NECROSIS FACTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL PNEUMONIA; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; HOST RESISTANCE; IMMUNITY; IMMUNOHISTOCHEMISTRY; KLEBSIELLA PNEUMONIAE; LETHALITY; MOUSE; NONHUMAN; SURVIVAL TIME; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DNA, COMPLEMENTARY; FEMALE; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, INBRED CBA; PNEUMONIA, BACTERIAL; SURVIVAL RATE; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033541515     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018300     Document Type: Article

References (31)

1. BAGBY, G.J., PLESSALA, K.J., WILSON, L.A., THOMPSON, J.J., and NELSON, S. (1991). Divergent efficacy of antibody against tumor necrosis factor-α in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163, 83-88.
2. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. U.S.A. 91, 8802-8811.
3. CAMPBELL, G.D. (1994). Overview of community acquired pneumonia. Prognosis and clinical features. Med. Clin. N. Am. 78, 1035-1048.
4. CENTERS FOR DISEASE CONTROL (CDC). (1997). Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States. MMWR 46, 813-815.
5. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.-S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
6. DAVIES, J. (1994). Inactivation of antibiotics and dissemination of resistance genes. Science 264, 375-382.
7. DEBS, R.J., FUCHS, H.J., PHILIP, R., MONTGOMERY, A.B., BRUNETTE, E.N., LIGGITT, D., PATTON, J.S., and SHELLITO, J.E. (1988). Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. J. Immunol. 140, 3482-3488.
8. GAMBLE, J.R., HARLAN, J.M., and KLEBANOFF, S.J. (1985). Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 82, 8667-8671.
9. GOSSELIN, D., DESCANCTIS, J., BOULE, M., SKAMENE, E., MATOUK, C., and RADZIOCH, D. (1995). Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63, 3272-3278.
10. GREENBERGER, M.J., STRIETER, R.M., KUNKEL, S.L., DANFORTH, J.M., LAICHALK, L.L., MCGILLICUDDY, D.C., and STANDIFORD, T.J. (1996a). Neutralization of MIP-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173, 159-165.
11. GREENBERGER, M.J., KUNKEL, S.L., STRIETER, R.M., LUKACS, N., BRAMSON, J., GAULDIE, J., GRAHAM, F., HITT, M., DANFORTH, J.M., and STANDIFORD, T.J. (1996b). IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157, 3006-3012.
12. HITT, M., BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1994). Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. J.E. Cellis, ed. (Academic Press, San Diego, CA), pp. 479-498.
13. KNOWLES, M.R., HOHNEKER, K.W., ZHOU, Z.Z., OLSEN, J.C., NOAH, T.L., HU, P.-C., LEIGH, M.W., ENGELHARDT, J.F., EDWARDS, L.J., JONES, K.M., GROSSMAN, M., WILSON, J.M., JOHNSON, L.G., and BOUCHARD, R.C. (1995). A controlled study of adenoviral-vector mediated gene transfer in nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333, 823-831.
14. KOLLS, J.K., NELSON, S., and SUMMER, W.R. (1993). Recombinant cytokines and pulmonary host defense. Am. J. Med. Sci. 306, 330-335.
15. KOLLS, J.K., LEI, D., NELSON, S., SUMMER, W.R., GREENBERG, S., and BEUTLER, B. (1995). Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171, 570-575.
16. LAICHALK, L.L., KUNKEL, S.L., STRIETER, R.M., DANFORTH, J., BAILIE, M., and STANDIFORD, T.J. (1996). Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64, 5211-5218.
17. LE, J., and VILCEK, J. (1987). Tumor necrosis factor and interleukin-1: Cytokines with multiple overlapping biological activities. Lab. Invest. 56, 234-248.
18. MALONEY, S.B., and WILLIAMS, W.J. (1995). Epidemic nosocomial pneumonia in the intensive care unit. Clin. Chest Med. 16, 209-223.
19. MARR, R.A., ADDISON, C.L., SNIDER, D., MULLER, W.J., GAULDIE, J., and GRAHAM, F.L. (1997). Tumor immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF-α. Gene Ther. 4, 1181-1188.
20. MCCOY, R.D., DAVIDSON, B.L., BLAKE, J.R., HUFFNAGLE, G.B., JANICH, S.L., LAING, T.J., and SIMON, R.H. (1995). Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1553-1560.
21. MOUSSA, K., MICHIE, H.J., CREE, I.A., MCCAFFERTY, A.C., WINTER, J.H., DHILLION, D.P., STEPHENS, S., and BROWN, R.A. (1994). Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49, 107-111.
22. OSWALD, I.P., WYNN, T.A., SHER, A., and JAMES, S.L. (1992). Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor required as a costimulatory factor for interferon γ-induced activation. Immunology 89, 8676-8680.
23. ROESSLER, B.J., HARTMAN, J.W., VALLANCE, D.K., LATTA, J.M., JANICH, S.L., and DAVIDSON, B.L. (1995). Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6, 307-316.
24. STANDIFORD, T.J., and HUFFNAGLE, G.H. (1997). Cytokines in host defense against pneumonia. J. Invest. Med. 45, 335-345.
25. SVARVA, C.W., RATNER, H., and MAELAND, J.A. (1985). Emergence of β-lactam multiresistant varients of gram-negative bacilli in the presence of cefotaxime. Scand. J. Infect. Dis. 17, 387-391.
26. TAKASHIMA, K., TATEDA, K., MATSUMOTO, T., IIZAWA, Y., NAKAO, M., and YAMAGUCHI, K. (1997). Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65, 257-260.
27. TAN, A.M., FERRANTE, A., GOH, D.H., ROBERTSON, D.M., and CRIPPS, A.W. (1995). Activation of the neutrophil bactericidal activity for non typeable Haemophilus influenza by tumor necrosis factor and lymphotoxin. Pediatr. Res. 37, 155-159.
28. TOEWS, G.B., GROSS, G.N., and PIERCE, A.K. (1980). The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am. Rev. Respir. Dis. 120, 559-566.
29. TRACEY, K.J., BEUTLER, B., LOWRY, S.F., and CERAMI, A. (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474.
30. WILSON, J.M. (1996). Molecular medicine. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187.
31. XING, Z., BRACIAK, T., JORDANA, M., CROITORU, K., GRAHAM, F.L., and GAULDIE, J. (1994). Adenovirus-medicated cytokine gene transfer at tissue sites. Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153, 4059-4069.